Guideline Recommendations for Testing of ALK Gene Rearrangement in Lung Cancer: A Proposal of the Korean Cardiopulmonary Pathology Study Group

Rearrangement of anaplastic lymphoma kinase (ALK) gene is the best predictor of response to crizotinib, an ALK tyrosine kinase inhibitor. However, the prevalence of the ALK fusion is low, so accurate patient identification is crucial for successful treatment using ALK inhibitors. Furthermore, most p...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Hyojin, Shim, Hyo Sup, Kim, Lucia, Kim, Tae-Jung, Kwon, Kun Young, Lee, Geon Kook, Chung, Jin-Haeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Society of Pathologists and The Korean Society for Cytopathology 2014
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3950228/
https://www.ncbi.nlm.nih.gov/pubmed/24627688
http://dx.doi.org/10.4132/KoreanJPathol.2014.48.1.1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3950228/
https://www.ncbi.nlm.nih.gov/pubmed/24627688
http://dx.doi.org/10.4132/KoreanJPathol.2014.48.1.1

Ejemplares similares